PREFERENTIAL COUPLING BETWEEN DOPAMINE-D2 RECEPTORS AND G-PROTEINS

被引:134
作者
MONTMAYEUR, JP [1 ]
GUIRAMAND, J [1 ]
BORRELLI, E [1 ]
机构
[1] INSERM, U184, UNITE BIOL MOLEC & GENIE GENET, 11 RUE HUMANN, F-67085 STRASBOURG, FRANCE
关键词
D O I
10.1210/me.7.2.161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The D2 dopamine receptor, an inhibitor of adenylyl cyclase, belongs to the family of seven transmembrane domain G-protein-coupled receptors. This receptor is encoded by two mRNAs produced from the same gene by alternative splicing, here referred to as D2L and D2S. The resultant proteins are identical except for an insertion of 29 amino acids in the putative third intracytoplasmic domain. This domain has been shown to be important for the coupling of this family of receptors to G-proteins. We have previously shown that there is differential inhibition of the adenylyl cyclase activity when these two receptors are produced in JEG3 cells; D2S is more efficient than D2L. To understand the molecular basis of such differential activity, we analyzed the G-proteins expressed in these cells. Here we show that Galphai2 is absent in this cell line. Moreover, it is possible to restore the same inhibitory activity obtained by D2S when an expression vector encoding this alpha-subunit is cotransfected with D2L. In addition, transfections of the two receptors in a recipient cell line containing the three Galphai subtypes confirm that the two receptors behave similarly. We conclude that the 29-amino acid insertion present in D2L allows it to interact specifically with Gai2. These data suggest that in vivo the function of activated D2 receptors is exerted by specific interactions with Gi-protein subtypes.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 32 条
  • [1] BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321
  • [2] REMOVAL OF PHOSPHORYLATION SITES FROM THE BETA-2-ADRENERGIC RECEPTOR DELAYS ONSET OF AGONIST-PROMOTED DESENSITIZATION
    BOUVIER, M
    HAUSDORFF, WP
    DEBLASI, A
    ODOWD, BF
    KOBILKA, BK
    CARON, MG
    LEFKOWITZ, RJ
    [J]. NATURE, 1988, 333 (6171) : 370 - 373
  • [3] A 2ND MOLECULAR-FORM OF D2 DOPAMINE RECEPTOR IN RAT AND BOVINE CAUDATE-NUCLEUS
    CHIO, CL
    HESS, GF
    GRAHAM, RS
    HUFF, RM
    [J]. NATURE, 1990, 343 (6255) : 266 - 269
  • [4] IDENTIFICATION OF G PROTEIN ALPHA-SUBUNITS IN RINM5F CELLS AND THEIR SELECTIVE INTERACTION WITH GALANIN RECEPTOR
    CORMONT, M
    MARCHANDBRUSTEL, YL
    VANOBBERGHEN, E
    SPIEGEL, AM
    SHARP, GWG
    [J]. DIABETES, 1991, 40 (09) : 1170 - 1176
  • [5] COTE TE, 1983, J NEURAL TRANSM, P139
  • [6] THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING
    DALTOSO, R
    SOMMER, B
    EWERT, M
    HERB, A
    PRITCHETT, DB
    BACH, A
    SHIVERS, BD
    SEEBURG, PH
    [J]. EMBO JOURNAL, 1989, 8 (13) : 4025 - 4034
  • [7] DELEAN A, 1982, MOL PHARMACOL, V22, P290
  • [8] GERHARDT MA, 1991, MOL PHARMACOL, V40, P707
  • [9] ALTERNATIVE SPLICING DIRECTS THE EXPRESSION OF 2 D2 DOPAMINE RECEPTOR ISOFORMS
    GIROS, B
    SOKOLOFF, P
    MARTRES, MP
    RIOU, JF
    EMORINE, LJ
    SCHWARTZ, JC
    [J]. NATURE, 1989, 342 (6252) : 923 - 926
  • [10] A VERSATILE INVIVO AND INVITRO EUKARYOTIC EXPRESSION VECTOR FOR PROTEIN ENGINEERING
    GREEN, S
    ISSEMANN, I
    SHEER, E
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (01) : 369 - 369